Latest blog articles

Last year’s COP28 has resulted in a ‘historic’ mention of fossil fuels in its final decision, be it in a rather limited way. Where does the EU, the forerunner in climate action, stand when it comes to the elimination of fossil fuels? This post highlights a few problematic features of the EU’s policy...

How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.

It’s been almost a month since the COVID-19 pandemic has drastically changed the way we live and work. Now that we are more used to, in a manner of speaking, the extraordinary measures to curtail the rampant spread of the virus, it’s time to seriously consider, and openly discuss, this crisis’...

This week I am having the pleasure of attending the 2019 BIO International Convention hosted in Philadelphia, Pennsylvania. The biggest global event of its kind, this international convention brings together stakeholders from across the biotechnologies. Whether it be from the health, agricultural or...

Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...

​On 6 June, IGIR fellow Dr. Iveta Alexovičová, Assistant Professor of International Economic Law, Faculty of Law, Maastricht University, delivered a lecture entilted "Substance alongside procedure - a lesson learned?".